SEARCH RESULT

Total Matching Records found : 48

Patents and the law -V Venkatesan

The implementation of Patents Act, as last amended in 2005, raises significant issues of immediate concern to patients across the world. INDIA'S Patents Act has an interesting history. Enacted first in 1911 as the Indian Patents and Designs Act in the colonial era, it primarily addressed the interests of inventors, who did not want their inventions infringed upon by anyone who copied them or adopted the methods used to make them....

More »

Need for new TB drugs

-The Hindu   Public sector participation in discovering, developing and making a drug available at affordable prices may be the only way to find new cures for diseases like TB, says Pof Samir Brahmachari on the occasion of World Tuberculosis Day Tuberculosis (TB), a raging problem in Europe and Americas till early 20 century, now predominantly affects the developing world where it continues to be a major health problem and is making in...

More »

A historic move to make drugs affordable-G Ananthakrishnan

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...

More »

TB turns invincible by Sonal Matharu

Discovery of a deadly form of TB in a Mumbai hospital  underscores mismanagement In December last, when doctors at Hinduja Hospital in Mumbai raised the alarm over a deadly form of tuberculosis, the Union health ministry was quick to refute the claim. In its press release on January 17, the ministry said the term “totally drug resistant TB” is “misleading”; it is neither recognised by the national programme for TB control...

More »

New ‘killer' bacteria on the prowl: article by Aarti Dhar

Millions of Indians are suspected to be carriers of the drug-resistant bug After the scary New Delhi metallo-beta-lactamase-1 or the “superbug” was detected two years ago, the world is now faced with the community-acquired methicillin-resistant staphylococcus aureus (ca-MRSA) bacterium that is resistant to almost all common antibiotics. In India, where poor hygiene and the availability of over-the-counter antibiotics lead to development of resistance, an estimated 100 to 200 million people are reportedly...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close